DNLI

Denali治疗

• Simply Wall St·12h ago

  Denali Therapeutics (DNLI) Dropped, So What Is Drawing Attention Now?

• NASDAQ·2d ago

  Denali Therapeutics Enters Oversold Territory (DNLI)

• Simply Wall St·09/16 15:23

  Denali Therapeutics (DNLI) Pulls Back As Pipeline Promise Keeps Fair Value In Focus

• Simply Wall St·09/12 10:18

  Denali Therapeutics (DNLI) Stock Looks Stretched On Fair Value Yet Reasonable On Book Value

• TipRanks·09/10 02:05

  Top Executive Makes Eye-Catching Move at Denali Therapeutics

• Simply Wall St·09/08 21:32

  Is Denali Therapeutics (DNLI) Still Undervalued On Its Mixed Valuation Signals?

• Simply Wall St·08/26 17:33

  Denali Therapeutics (DNLI) Stock Looks Rich On Book Value While Returns Stay Strong

• Dow Jones·08/25 17:57

  Denali Therapeutics Is Maintained at Buy by B. Riley Securities

• Dow Jones·08/25 17:57

  Denali Therapeutics Price Target Raised to $35.00/Share From $30.00 by B. Riley Securities

• Benzinga·08/25 17:47

  B. Riley Securities Maintains Buy on Denali Therapeutics, Raises Price Target to $35

• Simply Wall St·08/25 01:26

  Denali Therapeutics (DNLI) Stock Dropped, So Why Is It Drawing Fresh Attention?

• TipRanks·08/20 16:32

  Denali’s DNL921 Trial: Early Alzheimer’s Safety Data That Could Shape Long-Term Upside

• Seeking Alpha·08/19 12:01

  Denali Therapeutics: Bullish On Avlayah And Their Prospects

• Seeking Alpha·08/18 15:45

  Monopar: Licensing Agreement And Rolling NDA Submission Serve As Catalysts For 'Strong Buy'

• Simply Wall St·08/17 16:27

  Denali Therapeutics (DNLI) Could Be 42% Undervalued Following Its Earnings Report